12:49 Nov 18
Akums Drugs & Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Akums Drugs & Pharmaceuticals Ltd.
Industry Pharmaceuticals
12:49 Nov 18
Quality
0/100
Not Eligible
Valuation
11/100
Expensive Valuation
Technical
17/100
Technically Bearish
Strength
4
Weakness
4
Opportunity
0
Threats
2
-0.56 %
ROE %
-0.11 %
ROA %
0.00
EPS
50.36
BVPS
-0.09 %
Net Profit Margin
| Mar 2022 | Mar 2023 | Mar 2024 | ||
|---|---|---|---|---|
| Net Sales | 3671.89 | 3654.82 | 4178.18 | |
| Operating Expenses + | 3763.61 | 3316.86 | 4055.2 | |
| Raw Material | 2432.8 | 2249.87 | 2537.9 | |
| Increase Decrease in Cost | -87.74 | 24.04 | 12.34 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 507.76 | 590.13 | 646.86 | |
| Miscellaneous Expenses | 1699.21 | 896.4 | 1377.16 | |
| Operating Profit | -91.72 | 337.96 | 122.98 | |
| Other Income | 22.63 | 46.1 | 34.02 | |
| Depreciation | 94.68 | 112.81 | 125.64 | |
| Interest | 16.66 | 46.25 | 50.61 | |
| Profit before tax and exceptio.. | -180.42 | 225 | -19.24 | |
| Exceptional Items | -12.98 | -74.5 | -26.03 | |
| PBT | -193.4 | 150.5 | -45.28 | |
| Provision for Taxation | 57.68 | 52.48 | -46.07 | |
| Net Profit | -251.08 | 98.02 | 0.79 | |
| NET Profit after MI | -252.54 | 94.86 | -4.04 | |
| EPS | -17.65 | 6.63 | -0.28 | |
| Operating Profit Margin (%) | -2.5 | 9.25 | 2.94 | |
| Net Profit Margin (%) | -6.88 | 2.6 | -0.1 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | |
|---|---|
| Promoter | 75.30 |
| FII | 7.30 |
| MF | 5.20 |
| Public | 7.10 |
| Others | 5.10 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
